KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Change in Acquisitions & Divestments (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Change in Acquisitions & Divestments for 17 consecutive years, with $16.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 98.49% to $16.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $77.0 million, a 93.14% decrease, with the full-year FY2025 number at $77.0 million, down 93.14% from a year prior.
  • Change in Acquisitions & Divestments was $16.0 million for Q4 2025 at Bristol Myers Squibb, up from -$683.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $6.2 billion in Q4 2022 to a low of -$910.0 million in Q3 2021.
  • A 5-year average of $546.1 million and a median of $105.5 million in 2022 define the central range for Change in Acquisitions & Divestments.
  • Peak YoY movement for Change in Acquisitions & Divestments: tumbled 45600.0% in 2021, then skyrocketed 3000.0% in 2023.
  • Bristol Myers Squibb's Change in Acquisitions & Divestments stood at $1.5 billion in 2021, then soared by 307.5% to $6.2 billion in 2022, then tumbled by 99.34% to $41.0 million in 2023, then surged by 2490.24% to $1.1 billion in 2024, then plummeted by 98.49% to $16.0 million in 2025.
  • Per Business Quant, the three most recent readings for BMY's Change in Acquisitions & Divestments are $16.0 million (Q4 2025), -$683.0 million (Q3 2025), and $732.0 million (Q2 2025).